BNP Takes Credit Suisse’s Spot at the Stock Trading Table
(Bloomberg Opinion) -- BNP Paribas SA has long sought a spot at the top table of global stock-trading banks. Its push is finally starting to pay off.
The French bank has overtaken Swiss rival Credit Suisse Group AG with consistently better equities revenue over the past year, and it's hot on the heels of Britain's Barclays Plc, which has also been ploughing resources into this business.
BNP's efforts helped lift revenue across stock and bond trading by 53% in the first quarter versus the same period last year — far ahead of expectations and beating all rivals for growth. Combined with a strong performance in its other businesses, the bank reported group pretax profits of 3.3 billion euros ($3.5 billion), which were 50% ahead of forecasts, according to Bloomberg data.
Profits benefited from the revenue growth in trading but also from a lack of credit-related losses across traditional lending. BNP has minimal exposure to Russia-related risks, and its move away from credit cards — and toward corporate lending, wealthier clients and mortgages — has helped keep risk low in its commercial and personal banking arm.
BNP's stock and bond trading revenue was driven by the unusual conditions in the first quarter that boosted many investment banks' profits. A strong period of increased risk-taking and new investment right at the start of the year was followed by high volatility, uncertainty and investors searching for protection in March after Russia's invasion of Ukraine and a string of high inflation readings.
In fixed income, currencies and commodities, BNP's year-on-year revenue growth in dollar terms was in line with Barclays's but better than all the others, including Goldman Sachs Group Inc. Like rivals, it was helped by the jump in bond yields and interest-rate expectations among investors, as well as volatility in currencies and commodities.
BNP's bond, currency and commodity trading is linked more closely with the borrowing and hedging needs of ordinary companies than with the speculative activity of investment funds, which drives activity for many of its rivals. Despite this difference in customer base, this quarter will have been as unusually strong for BNP as for its main competitors.
On the equities side, a good part of BNP's growth has come from acquisitions. Its prime brokerage, which involves trading with and lending to hedge funds, has grown substantially since its deal to take over Deutsche Bank AG's operation in 2019. The last remaining clients were transferred to BNP in January this year. Last year, the bank also bought the 50% of shares it did not own in Exane, an equities broker that it had partnered with for 17 years.
BNP has said how much revenue Exane added to equities — 80 million euros out of its 424 million-euro year-on-year growth — but it didn't detail how much its new hedge fund clients bought in. Even if these two additions were only worth half of BNP's revenue gains, which is probably a conservative estimate for the prime brokerage, its underlying growth in equities would still have outpaced rivals during this standout quarter for markets.
What matters, though, is that the Exane and hedge-fund clients have provided a step up in scale that won't disappear and that BNP can build on.
It probably also got some hedge-fund clients from Credit Suisse's decision to shut its own prime brokerage after suffering losses from the collapse of Archegos Capital Management.
The French bank's shares trade at a higher multiple of forecast book value than European peers Barclays, Credit Suisse and Deutsche Bank. On this evidence, BNP's valuation deserves to be higher still.
More From Bloomberg Opinion:
- A Big Win for Italy as Its Old Boys Club Goes Down to Defeat: Rachel Sanderson
- The Hideous Strength of the U.S. Dollar: Marcus Ashworth
- Investors Have Deutsche Bank and Credit Suisse Upside Down: Paul J. Davies
This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.
Paul J. Davies is a Bloomberg Opinion columnist covering banking and finance. He previously worked for the Wall Street Journal and the Financial Times.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.